Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Sep 10, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 18, 2026Reported purchase · Form 4Karen L. Zaderej · $52.3KOpen the filing ↗
- Aug 17, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record1,23919 flagged findings
Reported transactions (Form 4)80since Jul 2, 2025 · and 2 other holdings
Corporate events (8-K)30since Jan 4, 2021
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
What the company does
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
Source: Wikipedia (CC BY-SA 4.0) · copied on Sep 3, 2026 · may not reflect recent changes.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-05-07share offering or dilution eventrecentOpen filing ↗“…total future minimum lease payments under non-cancellable leases at March 31, 2026 were as follows (in thousands): Operating…”
+1 more passage from the same document
- “…and at March 31, 2026 we had a total accumulated deficit of $1,189.8 million. Our operations have been financed primarily from…”
- 2026-05-07capital return (buybacks/dividends)recentOpen filing ↗“…11 — 29,911 — 29,911 Subtotal $ 209,134 $ 122 $ ( 1 ) $ 209,255 $ 4,990 $ 204,265 Total $ 298,206 $ 122 $ ( 1 ) $ 298,327 $ 94,062 $…”
+1 more passage from the same document
- “…in one institutional money market fund that has investments consisting primarily of Repurchase Agreements and U.S…”
- 2026-05-07regulatory investigationrecentOpen filing ↗“…12. Contingencies Legal Proceedings The Company is subject to various routine legal proceedings and claims incidental to its…”
+1 more passage from the same document
- “…control over financial reporting during the quarter ended March 31, 2026 covered by this Quarterly Report on Form 10-Q that have…”
- 2026-05-07Department of Justice inquiryrecentOpen filing ↗“…The first patients were dosed in both DME trials in February 2026 with enrollment completion expected in Q3 2026. Recent…”
+1 more passage from the same document
- “…to operate as a public company, such as insurance, software and contracted services. 12. Contingencies Legal Proceedings The Company…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 1,239)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Oct 7, 26SCHEDULE 13G/A ↗Passive stake · Federated Hermes, Inc. · 8.0% · event on Sep 30, 26 · amendment
- Sep 10, 268-K ↗Current report · Other events
- Sep 8, 26SCHEDULE 13G ↗Passive stake · JANUS HENDERSON GROUP Ltd. · 10.9% · event on Aug 31, 26
- Aug 17, 268-K ↗Current report · Other events
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Cormorant Asset Management, LP · 8.3% · event on Jun 30, 26 · amendment
- Aug 12, 26SCHEDULE 13G ↗Passive stake · Adage Capital Management, L.P. · 5.7% · event on Jun 30, 26
- Aug 5, 2610-Q ↗Quarterly report
- Aug 5, 268-K ↗Current report · Results
- Jul 31, 26SCHEDULE 13G ↗Passive stake · Vanguard Capital Management · 5.0% · event on Jun 30, 26
- Jul 30, 268-K ↗Current report · Other events
- Jul 28, 26SCHEDULE 13G/A ↗Passive stake · BlackRock, Inc. · 7.7% · event on Jun 30, 26 · amendment
Notice of proposed sale · 2 Form 144/A filingsshow all 2hide
- Jul 22, 26Form 144/A ↗Notice of proposed sale · amendment
- Jul 22, 26Form 144/A ↗Notice of proposed sale · amendment
- Jul 21, 26Form 144 ↗Notice of proposed sale
- Jul 17, 268-K ↗Current report · Entered a material agreement
- Jun 22, 268-K ↗Current report · A senior executive left or was appointed
- Jun 3, 26SCHEDULE 13G ↗Passive stake · Commodore Capital LP · 5.1% · event on May 27, 26
- May 27, 26Form 4 ↗Insider transaction
- May 15, 26SCHEDULE 13G/A ↗Passive stake · Paradigm BioCapital Advisors LP · 3.8% · event on Mar 31, 26 · amendment
- May 14, 268-K ↗Current report · Other events
- May 13, 26SCHEDULE 13G/A ↗Passive stake · Adage Capital Management, L.P. · 4.0% · event on Mar 31, 26 · amendment
1,239 filings on record, the oldest from Jan 25, 05.
Listing the 25 most recent filings of the 1,239 on record.
65248
- Jul 17, 26Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Jun 22, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Oct 17, 25Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Jun 20, 25A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jan 8, 25A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Oct 31, 24Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Sep 4, 24A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jun 21, 24A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Dec 8, 23Entered a material agreement+2 more in the same filing8-K 1.01 ↗
3 senior executive changes2023show all 3hide
- Oct 16, 23A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jul 10, 23A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jun 21, 23A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- May 18, 23Restructuring plan with committed costs+5 more in the same filing8-K 2.05 ↗
- Jan 23, 23Entered a material agreement+3 more in the same filing8-K 1.01 ↗
11 older filings not shown · The record reaches back to Nov 30, 07.
Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.
- Jun 17, 20Listing notice (8-K 3.01)8-K 3.01 ↗
- Apr 6, 20Restructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
- Jul 18, 16Restructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
- Jun 18, 08Past accounts declared unreliable and being restated8-K 4.02 ↗
- Jan 2, 08Listing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
The full record holds 6 stress filings.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- JANUS HENDERSON GROUP Ltd.10.9%Aug 31, 26SCHEDULE 13G ↗
- Cormorant Asset Management, LP8.3%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- Federated Hermes, Inc.8.0%Sep 30, 26SCHEDULE 13G/A ↗5 co-filers on this document — the figure is the largest single stake, not their sum.
- BlackRock, Inc.7.7%Jun 30, 26SCHEDULE 13G/A ↗1 earlier filing
- Adage Capital Management, L.P.5.7%Jun 30, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
show 4 more holdershide
- Commodore Capital LP5.1%May 27, 26SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
- Vanguard Capital Management5.0%Jun 30, 26SCHEDULE 13G ↗
- TCG Crossover GP II, LLC4.3%Dec 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
- Paradigm BioCapital Advisors LP3.8%Mar 31, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Jul 22, Lurker Nancy filed notice of intent to sell up to $16K.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
No sale of theirs is on record yet in Form 4; the 90-day window is still open.
View notice (Form 144) ↗+2 more recent notices
- Aug 18, 26Buy$52KKaren L. Zaderej↗
- Jun 30, 26Sell$37KRamiro RibeiroChief Medical Officer↗
- Jun 30, 26Sell$37KRamiro RibeiroChief Medical Officer↗
- Apr 17, 26Sell$37KRamiro RibeiroChief Medical Officer↗
- Mar 16, 26Buy$20KJay S. DukerPresident and CEO↗
- Mar 4, 26Sell$44KRamiro RibeiroChief Medical Officer↗
- Feb 17, 26Sell$37KRamiro RibeiroChief Medical Officer↗
- Jan 5, 26Sell$727KRamiro RibeiroChief Medical Officer↗
Stock compensation, tax and giftsshow the 32 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Aug 20, 26Otheramount n/aGeorge ElstonChief Financial Officer↗
- Aug 20, 26Otheramount n/aGeorge ElstonChief Financial Officer↗
- Aug 20, 26Giftamount n/aGeorge ElstonChief Financial Officer↗
- Aug 20, 26Giftamount n/aGeorge ElstonChief Financial Officer↗
- Jul 10, 26Compensationamount n/aJay S. DukerPresident and CEO↗
- Jul 10, 26Tax$119KJay S. DukerPresident and CEO↗
- Jun 30, 26Compensation$20KRamiro RibeiroChief Medical Officer↗
- Jun 30, 26Compensation$20KRamiro RibeiroChief Medical Officer↗
- May 25, 26Compensationamount n/aGeorge ElstonChief Financial Officer↗
- May 25, 26Tax$47KGeorge ElstonChief Financial Officer↗
- Apr 17, 26Compensation$20KRamiro RibeiroChief Medical Officer↗
- Mar 23, 26Other$1.0MJay S. DukerPresident and CEO↗
- Mar 23, 26Other$1.0MJay S. DukerPresident and CEO↗
- Mar 4, 26Compensation$20KRamiro RibeiroChief Medical Officer↗
- Mar 2, 26Giftamount n/aGeorge ElstonChief Financial Officer↗
- Mar 2, 26Giftamount n/aGeorge ElstonChief Financial Officer↗
- Feb 17, 26Compensation$20KRamiro RibeiroChief Medical Officer↗
- Jan 6, 26Compensationamount n/aGeorge ElstonChief Financial Officer↗
- Jan 6, 26Tax$76KGeorge ElstonChief Financial Officer↗
- Jan 6, 26Compensationamount n/aNancy Lurker↗
- Jan 6, 26Compensationamount n/aJay S. DukerPresident and CEO↗
- Jan 6, 26Tax$170KJay S. DukerPresident and CEO↗
- Jan 5, 26Compensationamount n/aGeorge ElstonChief Financial Officer↗
- Jan 5, 26Tax$77KGeorge ElstonChief Financial Officer↗
- Jan 5, 26Compensationamount n/aNancy Lurker↗
- Jan 5, 26Compensationamount n/aJay S. DukerPresident and CEO↗
- Jan 5, 26Tax$253KJay S. DukerPresident and CEO↗
- Jan 5, 26Compensation$242KRamiro RibeiroChief Medical Officer↗
- Jan 3, 26Compensationamount n/aGeorge ElstonChief Financial Officer↗
- Jan 3, 26Tax$111KGeorge ElstonChief Financial Officer↗
- Jan 3, 26Compensationamount n/aJay S. DukerPresident and CEO↗
- Jan 3, 26Tax$410KJay S. DukerPresident and CEO↗
The full record holds 263 transactions and goes back to Jan 6, 23.
Its sector and its market
EyePoint, Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From EyePoint, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow EyePoint, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- Series with incidents in the period; the chart shows what could be kept.
- SEC records
- 1,239 documents on file, from Jan 25, 2005 to Oct 7, 2026.
- Company description
- Wikipedia, read on Sep 3, 2026.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.